相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。BMS-936564/MDX-1338: A Fully Human Anti-CXCR4 Antibody Induces Apoptosis In Vitro and Shows Antitumor Activity In Vivo in Hematologic Malignancies
Michelle R. Kuhne et al.
CLINICAL CANCER RESEARCH (2013)
A review on CXCR4/CXCL12 axis in oncology: No place to hide
Urszula M. Domanska et al.
EUROPEAN JOURNAL OF CANCER (2013)
Inhibition of CXCR4 in CML cells disrupts their interaction with the bone marrow microenvironment and sensitizes them to nilotinib
E. Weisberg et al.
LEUKEMIA (2012)
Binding Modes of Thioflavin T Molecules to Prion Peptide Assemblies Identified by Using Scanning Tunneling Microscopy
Xiaobo Mao et al.
ACS CHEMICAL NEUROSCIENCE (2011)
Determination of relative binding affinities of labeling molecules with amino acids by using scanning tunneling microscopy
Chenxuan Wang et al.
CHEMICAL COMMUNICATIONS (2011)
Combination of drug therapy in acute lymphoblastic leukemia with a CXCR4 antagonist
R. Parameswaran et al.
LEUKEMIA (2011)
Beta structure motifs of islet amyloid polypeptides identified through surface-mediated assemblies
Xiao-Bo Mao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Development of resistance to dasatinib in Bcr/Abl-positive acute lymphoblastic leukemia
F. Fei et al.
LEUKEMIA (2010)
Can inhibition of the SDF-1/CXCR4 axis eradicate acute leukemia?
Sigal Tavor et al.
SEMINARS IN CANCER BIOLOGY (2010)
Targeting the leukemia microenvironment by CXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML
Zhihong Zeng et al.
BLOOD (2009)
Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100
Bruno Nervi et al.
BLOOD (2009)
Inhibition of the SDF-1α-CXCR4 axis by the CXCR4 antagonist AMD3100 suppresses the migration of cultured cells from ATL patients and murine lymphoblastoid cells from HTLV-I Tax transgenic mice
Akira Kawaguchi et al.
BLOOD (2009)
CXCR4 antagonists: targeting the microenvironment in leukemia and other cancers
J. A. Burger et al.
LEUKEMIA (2009)
Focal adhesion kinase is required for CXCL12-induced chemotactic and pro-adhesive responses in hematopoietic precursor cells
A. M. Glodek et al.
LEUKEMIA (2007)
CXCR4 antagonists mobilize childhood acute lymphoblastic leukemia cells into the peripheral blood and inhibit engraftment
J. Juarez et al.
LEUKEMIA (2007)
The CXCR4 chemokine receptor in acute and chronic leukaemia:: a marrow homing receptor and potential therapeutic target
Jan A. Burger et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Overexpression of CXCR4 predicts adverse overall and event-free survival in patients with unmutated FLT3 acute myeloid leukemia with normal karyotype
Sergej Konoplev et al.
CANCER (2007)
CXCR4 is a prognostic marker in acute myelogenous leukemia
Anke C. Spoo et al.
BLOOD (2007)
Inhibition of CXCR4 with the novel RCP168 peptide overcomes stroma-mediated chemoresistance in chronic and acute leukemias
Zhihong Zeng et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Tumor microenvironment and drug resistance hematologic malignancies
Zhi-Wei Li et al.
BLOOD REVIEWS (2006)
CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment
JA Burger et al.
BLOOD (2006)
Small peptide inhibitors of the CXCR4 chemokine receptor (CD184) antagonize the activation, migration, and antiapoptotic responses of CXCL12 in chronic lymphocytic leukemia B cells
M Burger et al.
BLOOD (2005)
In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftment
DA Sipkins et al.
NATURE (2005)
CXCR4 regulates migration and development of human acute myelogenous leukemia stem cells in transplanted NOD/SCID mice
S Tavor et al.
CANCER RESEARCH (2004)
Relation between CXCR-4 expression, Flt3 mutations, and unfavorable prognosis of adult acute myeloid leukemia
EJC Rombouts et al.
BLOOD (2004)
Chemokines and their receptors as therapeutic targets: The role of the SDF-1/CXCR4 axis
J Juarez et al.
CURRENT PHARMACEUTICAL DESIGN (2004)
Lipid bilayer simulations of CXCR4 with inverse agonists and weak partial agonists
JO Trent et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Effects of inhibitors of the chemokine receptor CXCR4 on acute lymphoblastic leukemia cells in vitro
J Juarez et al.
LEUKEMIA (2003)
Human bone marrow endothelial cells elaborate non-stromal-cell-derived factor-1 (SDF-1)-dependent chemoattraction and SDF-1-dependent transmigration of haematopoietic progenitors
DY Jo et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Stromal cells prevent apoptosis of AML cells by up-regulation of anti-apoptotic proteins
M Konopleva et al.
LEUKEMIA (2002)
A point mutation that confers constitutive activity to CXCR4 reveals that T140 is an inverse agonist and that AMD3100 and ALX40-4C axe weak partial agonists
WB Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
SDF-1-induced actin polymerization and migration in human hematopoietic progenitor cells
C Voermans et al.
EXPERIMENTAL HEMATOLOGY (2001)
The chemokine receptor CXCR4 enhances integrin-mediated in vitro adhesion and facilitates engraftment of leukemic precursor-B cells in the bone marrow
W Shen et al.
EXPERIMENTAL HEMATOLOGY (2001)